Clinical Trial Update: The RECOVER IV Trial [NA]

View source ↗

Summary

Abiomed's RECOVER IV trial, studying treatment for ST-segment Elevation Myocardial Infarction with Cardiogenic Shock, has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock
• St-segment Elevation Myocardial Infarction

Snippet

Sponsor: Abiomed Inc. | Conditions: ST-segment Elevation Myocardial Infarction (STEMI), Cardiogenic Shock | NA | Status: TERMINATED